grant

Contribution of ovarian cancer stem cells to chemoresistance and recurrent disease. [ 2015 - 2018 ]

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1081461]

Brief description Ovarian cancer is the most lethal gynaecological cancer. Previously, we showed that cancer stem cells are the “beating heart” of the ovarian cancer and are responsible for drug resistance and tumour relapse. The ineffective targeting of these cells by chemotherapy is accountable for the poor clinical outcomes in ovarian cancer patients. This project will define the molecular signals involved in maintenance of cancer stem cells and develop targeted therapies against these cells.

Funding Amount $AUD 378,940.38

Funding Scheme Project Grants

Notes New Investigator Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]
ACN 633 798 857